Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Revenue growth is our sticky wicket, yet 20% /Qtr = 100% YOY

<< Previous

Bullboard Posts

Next >>

Post by HomerAndCompanyon Nov 08, 2021 9:06am

242 Views

Post# 34099023

Revenue growth is our sticky wicket, yet 20% /Qtr = 100% YOY

The 20% per quarter revenue growth in the last two quarters translates into 100% growth on an anualized (compounded) basis. It was a miss, not what we were expecting, and certainly not what we were hoping for. But still, it is exponential growth in the face of COVID headwinds.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter